



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Sunday,
                        10 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1707






                                    ANSWERED ON: 
                                

02.07.2019






Pharmaceutical Research




Parvesh Sahib Singh














                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) whether there is any disease/virus/ epidemic in the country for which there is no drug/antidote available in the country as of June 2019 and if so, the details thereof; (b) the details of exclusive pharmaceutical research/inventions carried out in the country during the last five years; and (c) the total funds allocated for pharmaceutical research during the said period and the steps taken for promotion of pharmaceutical research and inventions in the country?






ANSWER




MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS(SHRI D. V. SADANANDA GOWDA)                               (a): The Department of Pharmaceuticals has no data regarding any disease/virus/epidemic in the country for which there is no drug/antidote available in the country.(b) & (C): The details of research and development activities being undertaken in the field of pharmaceuticals research is given at Annexure. AnnexureAnnexure referred to in part (b) & (c) of Lok Sabha Unstarred Question No. 1707 for reply on 02.07.2019 raised by Shri Parvesh Sahib Singh regarding ‘Pharmaceutical Research’.  (b) & (c): The details of research and development activities being undertaken in the field of pharmaceuticals research is as following:?	Council of Scientific & Industrial Research (CSIR) is implementing a Mission Mode Project on Active Pharmaceutical Ingredients to develop innovative and novel processes for soon to be generic nationally important APIs and also for key starting materials and intermediates for which Indian pharmaceutical industry is mainly dependent on China for its requirement. Selected molecules are: Daclatasvir; Ledipasvir; Nilotinib; Nicergolin; alpha-Lipoic acid; Sitagliptin; Sacubitril; Azelaic Acid; Paracetamol; Ibuprofen; Dolutegravir; Boscalid; Pregabalin; Avibactum.?	CSIR is implementing Phytopharmaceuticals Mission under which phytopharmaceutical development is being pursued along with related activities such as captive cultivation of medicinal plants including rare and endangered medicinal plants and technology for preparation of standardized extracts. The phytopharmaceutical development is being pursued as per regulatory guidelines of DCGI/AYUSH. Phytopharmaceutical development of Cassia occidentalis for Glucocorticoid-induced osteoporosis, Murraya koenigii for Cervical cancer, Dysoxylum binectariferum for Rheumatoid arthritis and Picrorhiza kurroa for Liver fibrosis is being pursued as per regulatory guidelines of DCG(I). Phytopharmaceutical development of Glycyrrhiza glabra for Diabetes, Cissampelos pareira for Anti-venom, Tinospora coridfolia for Cognitive impairment and Bergenia ciliate for Pain in Rheumatoid arthritis is being pursued as per regulatory guidelines of AYUSH. ?	CSIR is also implementing Sickle Cell Anaemia Mission for Managing Genetic Burden of Sickle Cell Anaemia and Understanding Genetic Basis of Differential Response to Hydroxyurea Therapy; Drug discovery and development for management of SCA; Genome editing and stem cell research approach for the treatment of SCA; and Development and on-ground implementation of an affordable, accurate and accelerated diagnostic kit. ?	Standardized extract of Dalbergia sissoo for fracture healing and management of post-menopausal osteoporosis has been launched for marketing on 17 Feb 2016 by our licensee M/s. Pharmanza Herbals Ltd., Gujarat. It is being marketed with brand name Reunion, an Ayurvedic Medicine.?	Technology of novel osteo-inductive agent CDRI S008-399 as medicated bone implant material for fracture healing has been transferred to M/s. OrthoRegenics Pvt., Ltd., Hyderabad. ?	IND has been filed for the Antithrombotic candidate drug S007-867 ?	Advanced level pre-clinical regulatory studies are ongoing for the fracture healing agent CDRI S007-1500. IND to be filed shortly. ?	Development of Non-invasive Premature Birth Prediction Kit?	Development of a biosimilar of Adalimumab for treatment of rheumatoid arthritis: scaling-up of upstream and downstream mAb production processesAs per the information received from CSIR, detail of their allocation on pharmaceuticals research is given below:(Rs. In Lakh)Year	2015-16	2016-17	2017-18	2018-19	19-20 (till date)R&D Budget	6063	4608	7747	9227	5252The Department of Science and Technology under Ministry of Science and Technology has been implementing a Plan Scheme (Drugs & Pharmaceuticals Research Programme – DPRP) since 1994-95 for promoting R&D in Drugs & Pharmaceutical Sector with the following objectives: •	To synergise the strengths of publicly funded R&D institutions and Indian Pharmaceutical Industry; •	To create an enabling infrastructure, mechanisms and linkages to facilitate new drug development; •	To stimulate skill development of human resources in R&D for drugs and pharmaceuticals; Under this programme grants-in-aid is extended to Indian Pharmaceutical industries for clinical trials – Phase-I, II and III for neglected diseases such as Tuberculosis, Malaria, Kala-Azar, Filariasis, etc. Since 2008-09, this programme supported four grants-in-aid projects to Indian Pharma industries for conducting trials in neglected diseases such as malaria, kala-azar etc.The total funds allocated to the Drugs & Pharmaceuticals Research Programme (DPRP) during the last five years is 100 Crores Indian Council for Medical Research (ICMR) has supported a total number of 20 pharmaceutical research projects during last five years. ICMR has set up Technical Advisory group for guidance of taking forward leads of research for product development.ICMR has released Rs. 2.57 crores for pharmaceutical research. xxxxx
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113078854







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







